YGION Biomedical

YGION Biomedical is a preclinical-stage private biopharmaceutical company located in Vienna, Austria, dedicated to advancing personalized immunotherapy for cancer. YGION’s YGNITE™ platform integrates next-generation sequencing, bioinformatics, and the proprietary CARGONAUT™ vaccine platform to deliver tailored neoepitope peptide vaccines for each tumor and every patient.